Landmark deal: Israeli companies team to market MMJ inhaler

420Patients.com is accepting qualified medical marijuana patients and caregivers to join our network. We value every registered member and we hope to serve you in Arizona. This article brought to you by 420 community friends mmjbusinessdaily.com

Two Israeli companies have signed an agreement to market an inhaler for medical marijuana, signifying what looks to be the first time a major global pharmaceutical company has agreed to market an MMJ product.

Teva Pharmaceutical Industries Ltd. and Syqe Medical said they inked a distribution and cooperation agreement for Teva to exclusively market Syqe’s inhaler, which has been used for more than a year at an Israeli hospital under a trial program, the Times of Israel reported.

Syqe said the deal is the first of its kind involving a big pharmaceutical company and a medical cannabis

Landmark deal: Israeli companies team to market MMJ inhaler is a post from: Marijuana Business Daily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs

Leave a Reply

Skip to toolbar